Key facts
- Vitayou’s last known valuation is $500K (May 2025).
- It has raised $150K.
- Notable investors include Murat Demirhan.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Vitayou
- ·The full record, as it builds
Funding rounds
No funding rounds for Vitayou are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vitayou
Developer of a personalized nutrition platform designed to optimize individual health through data-driven supplement routines tailored to users' lifestyles and biological profiles. The company offers a subscription-based service that analyzes users' nutrition habits, biological data and lifestyle inputs to deliver customized supplement plans, enabling customers to receive scientifically validated, targeted health support rather than generic solutions, enhancing trust, efficacy and long-term wellness.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Istanbul, Turkey
- Founded
- 2025
- Employees
- 2
- Website
- vitayou.co/
- Ownership
- Privately Held (backing)
Vitayou doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vitayou shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vitayou in its N-PORT filings yet. We sweep new filings monthly.